This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bernet FH, Baykut D, Grize L, Zerkowski HR . Single-center outcome analysis of 1161 patients with St Jude medical and ATS open pivot mechanical heart valves. J Heart Valve Dis 2007; 16: 151–158.
Emery RW, Emery AM, Raikar GV, Shake JG . Anticoagulation for mechanical heart valves: a role for patient based therapy. J Thromb Thrombolysis 2008; 25: 18–25.
Fecher AM, Birdas TJ, Haybron D, Papasavas PK, Evers D, Caushaj PF . Cardiac operations in patients with hematologic malignancies. Eur J Cardiothorac Surg 2004; 25: 537–540.
Sorror M . Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes. Biol Blood Marrow Transplant 2009; 15 (1 suppl): 149–153.
Ruel M, Chan V, Bédard P, Kulik A, Ressler L, Lam BK et al. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation 2007; 116 (11 suppl): 294–300.
Andersson BS, de Lima M, Thall PF, Wang X, Couriel D, Korbling M et al. Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and Cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS. Biol Blood Marrow Transplant 2008; 14: 672–684.
Petersen FB, Ford CD . Maximum supportive care, standard conditioning and allogeneic stem cell transplantation for elderly patients with acute myelogenous leukemia. Curr Opin Oncol 2009; 21 (Suppl 1): S7–S9.
Blaise D, Kuentz M, Fortanier C, Bourhis JH, Milpied N, Sutton L et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 2000; 18: 537–546.
Prebet T, Ladaique P, Ferrando C, Chabannon C, Faucher C, De Lavallade H et al. Platelet recovery and transfusion needs after reduced intensity allogeneic peripheral blood stem cell transplantation. Exp Hematol 2009; 38: 55–60.
Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol 2009; 10: 223–232.
Acknowledgements
TP thanks Dr G Maxant of the Cardiovascular Surgery Department, CHU Montpellier for research support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prébet, T., Devillier, R., Fürst, S. et al. Allogeneic hematopoietic SCT and mechanical heart valve: feasibility of reduced toxicity myeloablative conditioning. Bone Marrow Transplant 45, 1574–1575 (2010). https://doi.org/10.1038/bmt.2010.16
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.16